Patent details

Basic Information

Publication number:

93096

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP087985503

Legal Status:

Inactive

Application number:

93096

First applicant's nationality:

Procedural language:

French

Paediatric Extension

SPC Extension Filing Date:

21/03/2023

SPC Extension Agent Name:

OFFICE FREYLINGER S.A.

SPC Extension Status:

Pending & Published

SPC Extension Grant Date:

SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:

EU/1/15/1016 - Repatha - evolocumab

Marketing Authorization Type:

Marketing Authorization Date:

21/07/2015

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

01/06/2016

First Marketing Authorization date:

21/07/2015

Grant date:

01/08/2016

Activation date:

Publication date:

01/08/2016

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

21/07/2030

SPC Extension Expiration:

21/01/2031

Rejection date:

Withdrawal date:

Owner

From:

01/06/2016

 

 

Name:

Amgen Inc.

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

01/06/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

WALKER Nigel Pelham, Clinton

Address:

United States (US)

2

Name:

CHAN Joyce Chi, Yee

Address:

United States (US)

3

Name:

CAO Qiong

Address:

United States (US)

4

Name:

MEHLIN Christopher

Address:

United States (US)

5

Name:

SHAN Bei

Address:

United States (US)

6

Name:

SHEN Wenyan

Address:

United States (US)

7

Name:

KING Chadwick, Terence

Address:

Canada (CA)

8

Name:

PIPER Derek, Evan

Address:

United States (US)

9

Name:

JACKSON Simon, Mark

Address:

United States (US)

10

Name:

CARABEO Teresa, Arazas

Address:

United States (US)

11

Name:

KETCHEM Randal, Robert

Address:

United States (US)

Publication

Bulletin

Bulletin Heading:

SPCX1

Bulletin edition number:

2023/05

Publication date:

04/04/2023

Description:

Section G : Applications for extensions for pediatric use – I1E publication

Annual Fees

Annual Fee Due Date:

31/08/2028

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
21/03/2023	Publication	1
21/03/2023	FNET_DC_FRONTPAGE	1
21/03/2023	Outgoing Correspondence	1
21/03/2023	Application Form	3
21/03/2023	Marketing authorization	3
21/03/2023	Summary of the product caracteristics	73
21/03/2023	Paediatric investigation plan	1